| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.PHARMTHERA.2006.11.003 |
| P698 | PubMed publication ID | 17229466 |
| P2093 | author name string | Jesús Pintor | |
| Pilar Alarma-Estrany | |||
| P433 | issue | 3 | |
| P921 | main subject | physiology | Q521 |
| P304 | page(s) | 507-522 | |
| P577 | publication date | 2006-12-15 | |
| P1433 | published in | Pharmacology & Therapeutics | Q3378596 |
| P1476 | title | Melatonin receptors in the eye: location, second messengers and role in ocular physiology | |
| P478 | volume | 113 |
| Q28651497 | Agomelatine in the treatment of major depressive disorder: an assessment of benefits and risks |
| Q38093228 | Agomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: a critical review |
| Q98577688 | Changes in melatonin receptor expression in a murine model of glaucoma |
| Q43165755 | Circadian variation in the electroretinogram and the presence of central melatonin |
| Q39454848 | Description of the constitutive activity of cloned human melatonin receptors hMT(1) and hMT(2) and discovery of inverse agonists |
| Q38988747 | Effect of melatonin and analogues on corneal wound healing: involvement of Mt2 melatonin receptor. |
| Q50091496 | Effect of monochromatic light on circadian rhythmic expression of clock genes and arylalkylamine N-acetyltransferase in chick retina |
| Q39317854 | Effects of melatonin and its receptor antagonist on retinal pigment epithelial cells against hydrogen peroxide damage |
| Q38281152 | Effects of melatonin on Wi-Fi-induced oxidative stress in lens of rats |
| Q51645214 | Hypoxia-induced vascular endothelial growth factor secretion by retinal pigment epithelial cells is inhibited by melatonin via decreased accumulation of hypoxia-inducible factors-1α protein. |
| Q42749922 | Increased melatonin levels in aqueous humor of patients with proliferative retinopathy in type 2 diabetes mellitus |
| Q54337814 | Involvement of carbonic anhydrases in the ocular hypotensive effect of melatonin analogue 5-MCA-NAT. |
| Q38111675 | Is the melatonin receptor type 1 involved in the pathogenesis of glaucoma? |
| Q28078927 | Melatonin in Retinal Physiology and Pathology: The Case of Age-Related Macular Degeneration |
| Q43046164 | Melatonin potentiates glycine currents through a PLC/PKC signalling pathway in rat retinal ganglion cells |
| Q37755679 | Melatonin: a multitasking molecule |
| Q36748061 | Mood disorders, circadian rhythms, melatonin and melatonin agonists |
| Q39597036 | New quinoxaline derivatives as potential MT₁ and MT₂ receptor ligands. |
| Q47349614 | Non-24-Hour Sleep–Wake Rhythm Disorder in the Totally Blind: Diagnosis and Management. |
| Q46703435 | Novel bromomelatonin derivatives suppress osteoclastic activity and increase osteoblastic activity: implications for the treatment of bone diseases. |
| Q38031910 | Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential |
| Q53634760 | Oral treatment with the melatonin agonist agomelatine lowers the intraocular pressure of glaucoma patients. |
| Q37552532 | Physiology and pharmacology of melatonin in relation to biological rhythms |
| Q37569858 | Presence of melatonin in human tears |
| Q41992739 | Removal of melatonin receptor type 1 increases intraocular pressure and retinal ganglion cells death in the mouse. |
| Q38709300 | TRPV4 Stimulation Induced Melatonin Secretion by Increasing Arylalkymine N-acetyltransferase (AANAT) Protein Level |
| Q92384380 | The Effect of Melatonin on Anxiety and Pain of Tourniquet in Intravenous Regional Anesthesia |
| Q33998365 | The Retinal Pigment Epithelium in Health and Disease |
| Q37137215 | The effects of melatonin on anxiety and pain scores of patients, intraocular pressure, and operating conditions during cataract surgery under topical anesthesia. |
| Q37434418 | The end of a myth: cloning and characterization of the ovine melatonin MT(2) receptor. |
| Q39402838 | The role and therapeutic potential of melatonin in age-related ocular diseases. |
| Q37315390 | Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients. |
| Q34029266 | Urinary 6-sulfatoxymelatonin level in diabetic retinopathy patients with type 2 diabetes |
| Q37308360 | Urinary 6-sulphatoxymelatonin levels in patients with senile cataracts |
Search more.